Institutional Ownership Apellis Pharmaceuticals, Inc. (APLS)
This table provides information about the institutional ownership of Apellis Pharmaceuticals, Inc. (APLS). We have compiled data on the 337 institutions that hold shares in the stock, with a total of 111 Million shares, which have been reported (via 13F filing form) to have a value of $4.35 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Wellington Management Group LLP
Boston, MA |
May 15, 2024 Q1 2024 |
15,058,071
shares
|
$591 Million
0.16% of portfolio
|
Q1 2024
New holding
|
|
Eco R1 Capital, LLC
San Francisco, CA |
May 15, 2024 Q1 2024 |
11,357,425
shares
|
$446 Million
19.04% of portfolio
|
Q1 2024
Added 1.65%
|
|
Avoro Capital Advisors LLC
New York, NY |
May 15, 2024 Q1 2024 |
11,111,111
shares
|
$436 Million
7.87% of portfolio
|
Q1 2023
Added 4.58%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
9,505,866
shares
|
$373 Million
0.01% of portfolio
|
Q1 2024
Reduced 0.52%
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
5,494,591
shares
|
$216 Million
0.01% of portfolio
|
Q1 2024
Added 2.11%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 15, 2024 Q1 2024 |
4,605,721
shares
|
$181 Million
0.17% of portfolio
|
Q1 2024
Reduced 26.93%
|
|
Jennison Associates LLC
|
May 02, 2024 Q1 2024 |
3,240,513
shares
|
$127 Million
0.13% of portfolio
|
Q1 2024
Reduced 1.08%
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
2,909,528
shares
|
$114 Million
0.01% of portfolio
|
Q1 2024
Reduced 0.2%
|
|
Octagon Capital Advisors LP
New York, NY |
May 15, 2024 Q1 2024 |
2,806,980
shares
|
$110 Million
25.81% of portfolio
|
Q4 2023
Added 7.21%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 15, 2024 Q1 2024 |
2,459,246
shares
|
$96.5 Million
0.02% of portfolio
|
Q1 2024
Reduced 0.04%
|
|
Jpmorgan Chase & CO
New York, NY |
May 10, 2024 Q1 2024 |
2,214,309
shares
|
$86.9 Million
0.01% of portfolio
|
Q1 2024
Reduced 13.98%
|
|
Assenagon Asset Management S.A.
|
Apr 24, 2024 Q1 2024 |
2,023,614
shares
|
$79.4 Million
0.32% of portfolio
|
Q1 2024
Reduced 5.66%
|
|
Boxer Capital, LLC
San Diego, CA |
May 15, 2024 Q1 2024 |
1,726,000
shares
|
$67.7 Million
5.28% of portfolio
|
Q4 2023
Added 9.52%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
1,689,890
shares
|
$66.3 Million
0.01% of portfolio
|
Q1 2024
Added 3.63%
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
1,637,618
shares
|
$64.3 Million
0.01% of portfolio
|
Q1 2024
Reduced 47.12%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 15, 2024 Q1 2024 |
1,611,773
shares
|
$63.3 Million
0.04% of portfolio
|
Q1 2024
Added 88.07%
|
|
Artal Group S.A.
Luxembourg, N4 |
May 17, 2024 Q1 2024 |
1,315,282
shares
|
$51.6 Million
4.17% of portfolio
|
Q1 2024
Reduced 7.46%
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2024 Q1 2024 |
1,297,800
shares
|
$50.9 Million
1.72% of portfolio
|
Q1 2024
Added 40.73%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
1,186,082
shares
|
$46.6 Million
0.01% of portfolio
|
Q1 2024
Added 316.0%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 14, 2024 Q1 2024 |
1,073,234
shares
|
$42.1 Million
0.07% of portfolio
|
Q1 2024
Reduced 20.18%
|
|
Polar Capital Holdings PLC
London, X0 |
May 15, 2024 Q1 2024 |
1,054,440
shares
|
$41.4 Million
0.39% of portfolio
|
Q1 2024
Added 0.09%
|
|
Deep Track Capital, LP
Greenwich, CT |
May 15, 2024 Q1 2024 |
1,000,000
shares
|
$39.3 Million
1.94% of portfolio
|
Q1 2024
New holding
|
|
Fiera Capital Corp
Montreal, A8 |
May 01, 2024 Q1 2024 |
948,437
shares
|
$37.2 Million
0.17% of portfolio
|
Q1 2024
Added 3.19%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
928,624
shares
|
$36.4 Million
0.1% of portfolio
|
Q2 2023
Added 106.34%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 08, 2024 Q1 2024 |
924,562
shares
|
$36.3 Million
0.01% of portfolio
|
Q1 2024
Added 2.23%
|